IL6 and pulmonary arterial hypertension: BMPR2 loss-of-function mutations increase susceptibility to PAH [141], and BMPR2 pathway alterations are key features observed in PAH, contributing to aberrant inflammatory response through altered cytokines feedback regulation like the one described in vivo and in vitro for IL-6 in PASMCs [142,143].